Use and abuse of HOMA modeling.
By T. M. Wallace, J. Levy, D. Matthews. Diabetes Care, 2004
5,047 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/ba864470a8ecc25de83e6dd780e3833c29dabd9c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
- Martin Adiels
- S. Olofsson
- Hannele Yki-Järvinen
- Marja-Riitta Taskinen
- Oluf Pedersen
- B. K. Pedersen
- M. Quon
In Epidemiology
In Molecular Biology
Citations in the corpus
- Brain-derived neurotrophic factor (BDNF) and type 2 diabetes (2007, background): “uk/), since the original HOMA [21] tends to overestimate insulin resistance [22].”
- Overproduction of large VLDL particles is driven by increased liver fat content in man (2006, methodology): “The HOMA-IR (homeostasis model assessment for insulin resistance) was calculated from the fasting glucose and serum insulin concentrations as fasting insulin (mU/l)×fasting glucose (mmol/l)/22.5 [ 25 ].”
- A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk (2009, methodology): “HOMA-IR and HOMA-B was calculated using the HOMA2-calculato”
- Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. (2008, methodology): “HOMA or log (HOMA) is used extensively in large epidemiological studies, prospective clinical trials, and clinical research studies (29, 47, 100).”